The controversy about the immune stimulatory properties of lipoteichoic acid (LTA) from Staphylococcus aureus was solved recently by showing decomposition and inactivation of LT A obtained by conventional purification strategies, as well as pronounced LPS contamination of commercial preparations. By introducing a novel preparation method, the structure of bioactive LTA was elucidated. This structure was confirmed by chemical synthesis. In this work, synthetic LTA derivatives were employed to study the structure-function relationship of cytokine induction in human monocytes. Synthetic LTA induced the same cytokine pattern as highly purified natural LTA. The gentiobiose core could be omitted without affecting bioactivity. The polyglycerophosphate backbone amplified the response to the lipid anchor (~100-fold) only when substituted with D-alanine, whereas a-D-N-acetylglucosamine substituents could be omitted. Replacing D-alanine substituents with L-alanine reduced the activity of the molecule at least 100fold, indicating stereoselectivity. These results define for the first time the crucial patterns required for the immune recognition of LTA. The Journal of Immunology, 2003, 170: 4134-4138. B ecause we carry ten times more conunensal bacteria than human cells, the boundaries to the inner compartments of the body must be protected carefully by the immune system. However, in case of a bacterial infection that cannot be controlled, the activation of the immune system may escalate to a life-threatening sepsis. For Gram-negative bacteria, LPS is well established as the crucial stimulus of the irmate immune system, as injection into mice causes all known symptoms of sepsis (1). There is increasing evidence that lipoteichoic acid (LTA? from the cytoplasmic membrane of Gram-positive bacteria is an immunostimulatory Gram-positive counterpart to LPS (2). The importance of Gram-positive organisms in hospital infections has increased in the past three decades. In the last decade, Gram-positive organisms were identified as frequently as Gram-negative organisms as the cause of sepsis (3). Staphylococcus aureus is the most frequently isolated Gram-positive pathogen that causes infections (4), e.g., in trauma patients (5, 6). A further problem, apart from the increase of S. aureus infections, is the development of antibiotic resistance in this species (7, 8) . Many S. aureus strains are increasingly reported to resist all current antibiotics except for vancomycin, and now even strains with additional vancomycin resistance are found (9). Therefore, alternatives and adjuvants to antibiotics are requested. To identify these, it is important to understand the pathophysiology of this bacterial infection. Thus, we have addressed the role of lipotei- choic acid, which appears to represent a key pathogen-associated molecular pattern of S. aureus in immune activation.
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LTA molecules consist of up to 50 repeating poly-(polyolphosphate) units fixed in the cytoplasmatic membrane by a lipid anchor. They appear to be crucial for the vital functions of the bacteria because their biosynthesis is not halted even in case of phosphate deficiency. Their biological functions identified so far include binding of metal cations by the negatively charged polysaccharide chains (charge densities are regulated by amino acid substituents like D-alanine and D-lysine) (10) and regulation of the activity of autolytic enzymes (11, 12) . To the host, they represent patterns for immune recognition, similar to LPS.
The amphiphilic LTA molecule resembles LPS in that it also forms micelles, is also lipid anchored, and carries phosphate and repetitive subunits of carbohydrates. It is known that LTA is recognized by macrophages via membrane-associated CD14 and Toll-like receptor (TLR) 2, but does not require participation of LPS-binding protein in humans (13, 14) . Published results show that conunercial LTA preparations are often of poor quality. In many cases , significant activities reported could be attributed to LPS contaminations (15, 16) . Furthermore, appropriately purified, phenol-extracted LTA from S. aureus was found to be unable to induce cytokine release, a measure of immunostimulatory activity (17) . We have recently attributed this to a decomposition of LTA resulting during the usual phenol extraction procedure (18) . This decomposition was characterized by a loss of glycerophosphate units as well as D-alanine and a-D-N-acetylglucosamine (GlcNAc) substituents from the LTA backbone. Meanwhile, it is possible to purify essentially homogenous, biologically active LTA by a butanol extraction method described recently (19) . Furthermore, the chemical synthesis of biologically active LTA based on the structure of LTA from S. aureus was conducted (20) . Using this synthetic LTA, we confirmed the key role of n-alanine substituents for the immunostimulatory activity by exchanging them with L-alanine. This derivative was less active in the stimulation ofTNF-a release from whole blood than was the compound with D-alanine. Furthermore, we observed that the lipid anchor alone, after separation from the backbone or when synthesized chemically, still retained immunostirnulatory potential. However, the concentration-response curve was shifted to higher concentrations by at least two log-orders. After loss of one of the two fatty acids, the LTA anchor lost its cytokine stimulating activity (20) . Here we wanted to extend these results to define the structure-function relationship of the LTA molecule and relate it to cytokine patterns . For this purpose we used chemically synthesized and artificially modified LTA derivatives lacking defined subunits. Data are presented as means ± SEM. Statistical significance was determined by one-way ANOV A followed by Dunnett's Multiple Comparison Test (data were normalized by a log transformation). In case of two groups, data were analyzed by one-tailed paired ttest, which are both options of the GraphPad InStat 3.00 software (GraphPad, San Diego, CA). Cytokine levels are given per milliliter of blood, i.e., corrected for a dilution factor of 5 in the 20% blood incubation. 
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Synthetic LTA induces a cytokine pattern similar to native LTA
We recently synthesized a complete LTA molecule based on the structure of S. aureus LTA. It consists of a gentiobiosyl-sn-dimyristoylglycerol anchor joined to six glycerophosphate units carrying four D-alanine and one GlcNAc substituent and is therefore shorter than native LTA, which has 30-50 glycerophosphate units (19) .
Comparison of the release of several cytokines in human whole blood showed that synthetic and native LTA have the same potency and pattern ( Fig. 1) , except for some TNF-0' low responders who produced < 10 pg TNF-o/ml in response to the synthetic LTA. This implies that the synthetic LTA reflects the key structural requirements for immune activation as found in native LTA.
Comparison ofLTA with D-alanine, LTA with L-alanine, and LTA anchor-induced cytokine patterns
We confirmed our previous results concerning TNF-o-release (20) and extended the assessment of immunostimulatory activity of the LTA derivatives D-Ala-LTA and L-Ala-LTA and the LTA anchor by measurement ofIL-l[3, IL-6, IL-lO, and IL-8 (structures shown in Fig. 2, A and B) . We found similar patterns of cytokine release with stimulus concentrations from 1 ng/ml to 10 f.Lg/ml (only IL-8 release shown,
Generation ofperitoneal cell populations
Mice were put to sleep by terminal pentobarbital anesthesia (Narcoren; Merial, Halbergmoos, Germany) by i.v. injection into the tail vein. Ice-cold PBS (10 ml; PAA Laboratories, Linz, Austria) was injected into the peritoneal cavity after skinning the abdomen. Mice were shaken gently, and the lavage liquid was transferred into siliconized glass tubes (Vacutainer; BD Biosciences, Plymouth, u.K.) and centrifuged at 300 X g for 10 min. The cell pellet was resuspended in RPM I 1640 medium (BioWhittaker, Verviers, Belgium) containing 10% FCS (heat-inactivated; Biochrom, Berlin, Germany) and 100 Il.I/ml penicillin/streptomycin (Biochrom).
Differential blood cell counts were routinely performed with a Pentra 60 (ABX Diagnostics, Montpellier, France) to exclude acute infections of blood donors. Incubations of human whole blood with LTA derivatives were performed essentially as described (21) . Briefly, 200 fLl heparinized blood freshly taken from healthy volunteers was diluted 5-fold with isotonic sodium chloride solution (0.9%; Boehringer Ingelheim, Ingelheim, Germany). LTA was sonified before use to dissolve micelles. After addition of the LTA stimuli in a volume of 10 fLl, incubations were conducted in polypropylene reaction tubes (Brinkmann Instruments, Hamburg, Germany) in the presence of 5% CO 2 at 37°C overnight. Cell-free supernatants were obtained by centrifugation at 400 X g for 2 min and stored at -70°C for cytokine determination.
TLR2 knockout mice were generated by homologous recombination and kindly provided by Tularik (South San Francisco, CA). TLR2 receptordeficient mice and the corresponding wild-type mice (l29Sv/B57BL/6) were bred in the animal house of the University of Konstanz (Konstanz, Germany). Husbandry conditions were 25°C, humidity 55%, 12-h daynight rhythm, and nutrition with Altromin C 1310 (Altromin, Lage, Germany). All animals received humane care in accordance with the National Institutes of Health guidelines and the legal requirements in Germany.
The general strategy of synthesis of lipoteichoic derivates was adopted with modifications as reported (20) . The detailed synthesis has been published (22) . The identities of the molecules were characterized by matrixassisted laser desorption-ionization time-of-flight mass spectrometry and nuclear magnetic resonance (NMR) at 600.13 MHz and 300 K. The NMR spectra were related to 3-(trimethysilyl) 3,3,2,2-tetradeuteropropionic acid Na salt (d 4-TSPA). According to NMR data, purities of LTA derivates were >98%. The synthetic LTA and the biological LTA were negative in the Limulus test for Gram-negative endotoxin (i.e., <1 IU LPS/mg LTA, Endosafe Limulus amoebocyte lysate Endochrome; Charles River Laboratories, Charleston, SC), excluding significant LPS contamination. The m.w. of the substances was 2248.90 for LTA with D-alanine (D-Ala-LTA) or with L-alanine (L-Ala-LTA), 1924.70 for LTA without gentiobiose, and 2116.8 for LTA in which GlcNAc was replaced with a o-alanine, LPS from Salmonella abortus equi was purchased from Sigma-Aldrich (Deisendorfen, Germany).
Incubation conditions ofperitoneal cell populations
Cell populations were transferred to 96-well cell culture plates (Cellstar; Greiner, Frickenhausen, Germany) at 10 5 peritoneal cells/well. Each well contained a total volume of 200 fLl RPMI 1640 (10% FCS and 100 ID/ml penicillin/streptomycin). For the determination of cytokine induction by LTA or LPS, cells were incubated with stimuli dissolved in pyrogen-free saline (Ampuwa; Fresenius Medical Care, Bad Homburg, Germany) at 37°C, 5% CO 2 , and humidified air overnight. Cell-free supernatants were stored at -70°C. 3 ). Though the lipid anchor of LTA represents a key component necessary for its biological activity, it was less potent in inducing IL-8 release than D-Ala-LTA. IL-8 was released in whole blood incubations upon D-Ala-LTA stimulation starting at concentrations as low as lOO ng/ml, whereas no IL-8 was released when L-Ala-LTA concentrations below I f.Lg/ml or LTA anchor concentrations lower than 10 f.Lg/ml were used. The molarity of the LTA anchor is about 3-fold higher in comparison to D-Ala-LTA at the same concentration. At equal molarity, the difference in cytokine release would be even more pronounced. Similar concentration dependencies were observed upon measurement ofIL-I{3, IL-6, TNF-a, and IL-lO (data not shown) . The minor activity of L-Ala-LTA was again seen for all cytokines measured. Replacing D-alanine by L-alanine attenuated the stimulatory activity indicating stereoselective recognition. It might be speculated that D-alanine substituents enable ionic interactions between LTA molecules forming multimers. Either L-alanine does not enable ionic interactions as well as D-alanine, or L-Ala-LTA itself is not recognized equally well by monocyte receptors.
Whole blood cytokine response
Based on these results which indicate that the LTA anchor alone has little inununostimulatory activity, we utilized further modified LTA molecules to characterize functional requirements for LTA activity. Next, two molecules were synthesized which lack either the GlcNAc or the gentiobiose subunits.
Role ofGlcNAc substituents in the induction of cytokine release byLTA
First we used the synthetic LTA that corresponds to D-Ala-LTA without GlcNAc substituents. GlcNAc was replaced by a further D-alanine substituent. We tested whether the absence of GlcNAc had an influence on cytokine release in comparison to D-Ala-LTA. The cytokine release was of a similar extent in response to D-Ala-LTA and synthetic LTA without GlcNAc over a concentration range from I ng/ml to 10 f.Lg/ml regarding TNF-a, IL-I{3, and IL-8 (Fig . 4) as well as IL-6 and IL-lO (not shown) . Both induced a whole blood cytokine response starting at as little as 100 ng/ml and increasing steadily up to 10 f.Lg/ml. It seems that the GlcNAc substituent plays no decisive role in the biological activity of LTA.
Some cytokine levels induced by LTA without GlcNAc were slightly higher than those induced by D-Ala-LTA. It might be speculated that the higher degree of substitution with D-alanine increases the immunostimulatory potency of the molecule. 
Cytokine response to D-Ala-LTA and LTA without gentiobiose
Next, we constructed a synthetic LTA that does not possess the gentiobiose subunit. We again quantified the release of several cytokines by stimulation with concentrations from 1 ng/ml to 10 f.Lg/ml (Fig. 5) . The loss of gentiobiose also had no significant effect on cytokine release. All cytokine levels measured were similar for D-Ala-LTA and LTA without gentiobiose. Therefore, we conclude that the gentiobiose does not represent an important factor for the immunostimulatory activity of LTA.
TLR2 dependency ofLTA derivates
Peritoneal cell populations from TLR2 knockout mice and wildtype mice (n = 4) were stimulated with 10 f.Lg/ml of native LTA, D-Ala-LTA, L-Ala-LTA, LTA without gentiobiose, LTA without GlcNAc or endotoxin (LPS). After overnight incubation, murine IL-6 was measured in the supernatants by sandwich ELISA. IL-6 release after stimulation with native LTA or LTA derivatives of TLR2-deficient peritoneal cells did not surpass control levels (0.11 ± 0.03 ng IL-6/ml), whereas native LTA (11.9 ± 1.5 ng IL-6/ml) and all LTA derivatives (e.g., D-Ala-LTA, 4.4 ± 0.7 ng IL-6/ml; LTA without gentiobiose, 2.5 ± 0.9 ng IL-6/ml) induced IL-6 in wild-type cells. We conclude that TLR2 is the receptor employed by native LTA as well as LTA derivatives. IL-6 release in response to stimulation with LPS was the same in TLR2-deficient and wild-type cells (7.3 ± 0.6 vs 8.2 ± 0.9 ng IL-6/ml, respectively). Taken together, the key components of the LTA molecule necessary for stimulation of monocytes are the LTA anchor with two fatty acids and a glycerophosphate backbone with D-alanine substituents. The exchange of D-alanine by L-alanine reduced the immunostimulatory potency significantly, which implies stereoselective recognition. In addition, we observed that the loss of the GlcNAc or gentiobiose had no decisive effect on the cytokine release in human whole blood, indicating that these components are not required for host recognition. It remains to be elucidated which minimal structure of LTA is required for potent cytokine release, i.e., we next intend to examine the immunostimulatory potential of LTA with a minimal backbone .
